Freshpet (FRPT) is back in focus after reporting second quarter 2026 results on 5 August, lifting its 2026 outlook and completing a share repurchase that retired 3.26% of its stock.
See our latest analysis for Freshpet.
The earnings beat and higher 2026 and 2027 guidance have drawn attention to Freshpet, yet the stock closed at US$66.73 after a 1 day share price decline of 6.63% following a 30 day share price return of 22.42% and a 1 year total shareholder return of 4.30%. This indicates near term momentum has picked up while longer term returns have been weaker.
If Freshpet's recent move has you thinking about where else growth stories could emerge, it may be worth scanning for pet care and consumer brands among the 20 top founder-led companies
Freshpet now has stronger earnings, higher guidance and a completed buyback all in play, yet the stock just pulled back after a sharp run. Is this a solid business that is simply being priced too richly today?
Freshpet's most followed narrative sets a fair value of $81.94 against the last close at $66.73, framing the stock as materially undervalued on that view.
Operational improvements and implementation of new production technologies at Ennis and other facilities have driven higher yields, quality, and throughput, leading to a significant reduction in CapEx ($100 million less over 2025-26) and enhanced gross/EBITDA margins, setting the business up for improving net earnings and cash generation.
Curious what kind of revenue path and margin reset need to line up to support that higher fair value. The narrative leans on specific growth, profitability and valuation assumptions that many investors may find surprisingly bold.
Result: Fair Value of $81.94 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Freshpet's story can change quickly if dog food category growth stays weak or if premium trade up slows, which could undercut those margin and revenue assumptions.
Find out about the key risks to this Freshpet narrative.
The fair value narrative for Freshpet leans on discounted cash flows. The market is also sending a different signal through the P/E ratio. The stock trades on 15.9x earnings, above a fair ratio of 12.9x, yet below both the peer average at 18x and the US Food industry at 16.7x. That mixed picture raises a simple question: Is the gap to the fair ratio pointing to valuation risk or to a market that is still recalibrating expectations?
For a closer look at how these earnings multiples stack up in practice, including where the fair ratio could pull the P/E over time, See what the numbers say about this price — find out in our valuation breakdown.
With Freshpet attracting both optimism and concern, this is a moment to review the numbers yourself and decide how convincing the story feels. To weigh both sides quickly and form your own view, start with the 3 key rewards and 2 important warning signs.
If Freshpet has sharpened your focus on quality businesses, do not stop here. Use the Simply Wall Street Screener to uncover other opportunities that fit your goals.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com